Path
Blood Sugar
Mitochondrial overload, not pancreatic failure. Research reframes type 2 diabetes as a metabolic substrate problem solved upstream of glucose itself.
For: Pre-diabetic, insulin-resistant, or A1c climbing into the 5.7+ zone.
◆ 10 quizzes◆ 10 slide decks◆ 10 audio
Learning objectives · Bloom-aligned · 11
- understandExplain the mitochondrial overload model of insulin resistance and why pancreatic beta-cell failure is a downstream consequence rather than the initiating lesion
- analyzeAnalyze how MOTS-c restores mitochondrial substrate handling and positions upstream of GLP-1 agonism, NNMT inhibition, and lifestyle levers in the metabolic hierarchy
- applyApply the Phase 1 Tirzepatide + MOTS-c reset protocol across weeks 1-4 including dose titration, injection cadence, and insulin-demand reduction checkpoints
- applyApply the Phase 2 layering of 5-Amino-1MQ across weeks 5-10 to inhibit NNMT, rescue NAD+ pools, and preserve lean mass during continued GLP-1 exposure
- analyzeAnalyze the cortisol-thyroid-circadian axis as it drives dawn phenomenon, morning fasting glucose elevation, and stalled responders
- evaluateEvaluate leading metabolic markers — fasting insulin, HOMA-IR, C-peptide, triglyceride/HDL ratio, and CGM-derived glucose variability — against lagging HbA1c to detect protocol response early
- createCreate a personalized weeks 1-4 execution calendar mapping Tirzepatide titration, MOTS-c dosing days, lab pull windows, and daily tracking inputs
- createCreate a weeks 5-10 layered execution plan integrating 5-Amino-1MQ without compromising Tirzepatide compliance, training load, or sleep architecture
- evaluateEvaluate clear-responder, partial-responder, and non-responder lab patterns to determine compound adjustment, dose escalation, or upstream axis intervention
- analyzeAnalyze the distinction between compounds run continuously for sustained mitochondrial capacity versus those cycled to preserve receptor sensitivity in long-term maintenance
- createCreate a post-protocol maintenance architecture that preserves metabolic flexibility across years using cycled GLP-1 exposure, continuous mitochondrial support, and quarterly lab cadence
Chapters · 10
- 01What's actually happening in insulin resistance
- 02Chapter 2 — The upstream lever: mitochondrial capacity
- 03Phase 1 reset — Weeks 1-4
- 04Phase 2 rebuild weeks 5-10-5 amino 1mq layered
- 05Supporting axis — cortisol, thyroid, and circadian glucose
- 06Labs that matter — what to pull, when, how to read
- 07Weeks 1-4 execution — daily and weekly rhythm
- 08Weeks 5-10 execution phase 2 layered
- 09Chapter 9 — Adjusting based on labs: three response scenarios
- 10Maintenance — sustained metabolic flexibility
Research use only · Not medical advice